MA49393A - Poly(phosphoesters) destinés à l'administration d'acides nucléiques - Google Patents

Poly(phosphoesters) destinés à l'administration d'acides nucléiques

Info

Publication number
MA49393A
MA49393A MA049393A MA49393A MA49393A MA 49393 A MA49393 A MA 49393A MA 049393 A MA049393 A MA 049393A MA 49393 A MA49393 A MA 49393A MA 49393 A MA49393 A MA 49393A
Authority
MA
Morocco
Prior art keywords
phosphoesters
administration
poly
intended
nucleic acids
Prior art date
Application number
MA049393A
Other languages
English (en)
Inventor
Frank Derosa
Michael Heartlein
Shrirang Karve
Yi Zhang
Original Assignee
Translate Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Translate Bio Inc filed Critical Translate Bio Inc
Publication of MA49393A publication Critical patent/MA49393A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G79/00—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/53—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F293/00—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G79/00—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
    • C08G79/02—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule a linkage containing phosphorus
    • C08G79/04—Phosphorus linked to oxygen or to oxygen and carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA049393A 2017-06-12 2018-06-11 Poly(phosphoesters) destinés à l'administration d'acides nucléiques MA49393A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762518313P 2017-06-12 2017-06-12

Publications (1)

Publication Number Publication Date
MA49393A true MA49393A (fr) 2020-04-22

Family

ID=62909585

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049393A MA49393A (fr) 2017-06-12 2018-06-11 Poly(phosphoesters) destinés à l'administration d'acides nucléiques

Country Status (4)

Country Link
US (1) US11530298B2 (fr)
EP (2) EP4047039A1 (fr)
MA (1) MA49393A (fr)
WO (1) WO2018231709A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019222277A1 (fr) * 2018-05-15 2019-11-21 Translate Bio, Inc. Administration sous-cutanée d'arn messager
EP4395748A1 (fr) 2021-09-03 2024-07-10 CureVac SE Nouvelles nanoparticules lipidiques pour l'administration d'acides nucléiques
EP4422698A1 (fr) 2021-10-29 2024-09-04 CureVac SE Arn circulaire amélioré pour exprimer des protéines thérapeutiques
WO2023144330A1 (fr) 2022-01-28 2023-08-03 CureVac SE Inhibiteurs de facteurs de transcription codés par un acide nucleique
WO2023227608A1 (fr) 2022-05-25 2023-11-30 Glaxosmithkline Biologicals Sa Vaccin à base d'acide nucléique codant pour un polypeptide antigénique fimh d'escherichia coli
US20240156949A1 (en) 2022-10-28 2024-05-16 Glaxosmithkline Biologicals Sa Nucleic Acid Based Vaccine
WO2024184500A1 (fr) 2023-03-08 2024-09-12 CureVac SE Nouvelles formulations de nanoparticules lipidiques pour l'administration d'acides nucléiques

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5132418A (en) 1980-02-29 1992-07-21 University Patents, Inc. Process for preparing polynucleotides
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4401796A (en) 1981-04-30 1983-08-30 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US5153319A (en) 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides
US5262530A (en) 1988-12-21 1993-11-16 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5047524A (en) 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US6184389B1 (en) * 1994-01-11 2001-02-06 Isis Pharmaceuticals, Inc. Combinatorial libraries having aminodiol monomer subunits
US5700642A (en) 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
AU2001247346A1 (en) * 2000-03-10 2001-09-24 Johns Hopkins University Phosphate based biodegradable polymers
US7345138B2 (en) * 2001-05-14 2008-03-18 Johns Hopkins Singapore Pte Ltd. Biodegradable polyphosphates for controlled release of bioactive substances
CA2659301A1 (fr) 2006-07-28 2008-02-07 Applera Corporation Analogues de coiffes de nucleotide d'arnm
WO2009058911A2 (fr) 2007-10-31 2009-05-07 Applied Biosystems Inc. Préparation et isolement d'un arnm coiffé en 5'
ES2797974T3 (es) 2013-03-14 2020-12-04 Translate Bio Inc Acidos ribonucleicos con nucleótidos modificados con 4-tio y procedimientos relacionados
US20210137846A1 (en) 2018-04-25 2021-05-13 Ethris Gmbh Cryoprotective agents for particulate formulations

Also Published As

Publication number Publication date
EP3638716B1 (fr) 2022-01-05
EP4047039A1 (fr) 2022-08-24
US11530298B2 (en) 2022-12-20
WO2018231709A1 (fr) 2018-12-20
US20200277446A1 (en) 2020-09-03
EP3638716A1 (fr) 2020-04-22

Similar Documents

Publication Publication Date Title
MA49393A (fr) Poly(phosphoesters) destinés à l'administration d'acides nucléiques
MA47824A (fr) Administration polyanionique d'acides nucléiques
MA52709A (fr) Administration d'adn
CL2020002043A1 (es) Métodos y composiciones para la entrega de proteínas terapeuticas.
MA46466A (fr) Formulations pharmaceutiques de protéines à viscosité réduite
MA48050A (fr) Lipides biodégradables pour l'administration d'acides nucléiques
MA45472A (fr) Systèmes d'administration pour la libération contrôlée de médicaments
MA50155A (fr) Acides aminés à chaîne ramifiée pour le traitement d'une lésion neuronale
MA46621A (fr) Traitements combinés comprenant l'administration d'imidazopyrazinones
DK3634377T3 (da) Farmaceutisk formulering
ITUB20153015A1 (it) Dispositivo per l'infusione di fluidi
ITUA20161408A1 (it) Macchina e procedimento per la preparazione di medicamenti intravenosi
MA43705A (fr) Formulation pharmaceutique
MA43873A (fr) Dspositif d'injection
MA45158A (fr) Composition pharmaceutique comprenant de l'éteplirsen
DK3601277T3 (da) Farmaceutisk formulering
MA45451A (fr) Formulations tensioactives destinées à l'inhalation
DK3432887T3 (da) Anti-tuberkulosemiddel
MA54243A (fr) Composé de 1,3,4-oxadiazolone et médicament
IT201700038005A1 (it) Dispositivo per la somministrazione di sostanze
MA46642A (fr) Promédicaments d'inhibiteurs de la kallicréine
DK3996688T3 (da) Farmaceutisk præparat
IT201700123080A1 (it) Macchina per l'assemblaggio di dispositivi medicali.
MA52268A (fr) Seringue à distribution contrôlée
IT201600090052A1 (it) Peptide per la diagnosi differenziale della Malattia di Crohn